Diff Profiles › MTBLS3893_0001_00000001

Decane_vs_Difluorodecane

Decane vs Difluorodecane

p-value ≤ 0.05 33 significant 2025-09-26 00:00:00 Study: MTBLS3893
38 Total Features
33 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS3893_0001_00000001
Linked study
MTBLS3893 — <i>Pseudomonas</i> sp. Strain 273 Incorporates Organofluorine into the Lipid Bilayer during Growth with Fluorinated Alkanes
Comparison
Decane vs Difluorodecane
Group A
Samples treated with Decane. Serves as a baseline treatment group for comparison with fluorinated treatments
Group B
Samples treated with Difluorodecane. Allows for assessment of the effects of difluorinated compounds on the organism
Total features tested
38
Significant features
33
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
YMEQXDCYZVOOFR-NOLSVFIGSA-N [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate up 49.58 2.95e-07
JEGMUNDQDSSICV-SZAHLOSFSA-N [(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] octadecanoate up 51.77 1.14e-06
ILDWNJKEBWLREM-DCLNZNATSA-N — up 30.25 1.91e-06
JPRWHUSRRGNLOV-KKUBIFFLSA-N Phosphatidylglycerol(18:0/18:2) up 22.78 1.64e-06
LKUKJIYAXQFZTD-MRDDHZETSA-N [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-octadec-11-enoate up 12.98 1.23e-07
LPQPHLDFHDAGBP-SIFNWRCISA-N — up 13.16 2.51e-06
AZKOMSGSPCBHKK-AVKQKRQHSA-N — up 24.08 3.03e-05
OUEUPCHAIFZTKH-LSWZYRHBSA-N [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate up 8.314 3.56e-07
IFVBZNWVWZLXTQ-WQQOROIJSA-N — up 23.63 6.18e-05
QCCFIGOPROAYMX-NHZJTUAKSA-N — up 22.62 8.77e-05